Latest News & Features
Refine Search
Big Pharma
Sanofi and GlaxoSmithKline are pooling resources to create a vaccine for COVID-19, in what they call an “unprecedented” collaboration between the two pharma companies. 14 April 2020
Americas
The US Court of Appeals for the Federal Circuit has ordered a new trial in a patent dispute between Abbott-subsidiary Alere and patent monetisation company Rembrandt Diagnostics. 14 April 2020
Americas
The US International Trade Commission is investigating ‘grey market’ in vitro fertilisation products intended for the Turkish market, following a trademark complaint from German pharmaceutical company Merck KGaA. 14 April 2020
Americas
A California federal judge has issued a final award of $1.2 billion in damages to Bristol-Myers Squibb subsidiary Juno Therapeutics in its patent infringement dispute with Gilead’s Kite Pharma. 9 April 2020
Africa
The International Community of Breeders of Asexually Reproduced Ornamental and Fruit Varieties has implored countries to implement support measures for breeders amid the pandemic. 9 April 2020
Americas
Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23. 9 April 2020
Big Pharma
The EU’s drugs regulator has set up a fast-track system to monitor shortages during the COVID-19 pandemic. 8 April 2020
Big Pharma
Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU. 7 April 2020
Americas
Notorious ‘pharma bro’ Martin Shkreli and his former drug company Retrophin want antitrust claims filed against them in federal court dismissed. 6 April 2020
Europe
Mewburn Ellis has appointed a new life sciences-focused partner as part of a number of promotions in its IP team. 6 April 2020